ID   OS9_HUMAN               Reviewed;         667 AA.
AC   Q13438; A6NDD1; A6NFR7; A6NLB2; A8K5Q9; B4DE28; B4DPX1; B4E1I6; E7ENT8;
AC   E7EW91; F8VUH2; G3XA88; O00579; Q6IBL2; Q8IZ58; Q9BW99;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   03-AUG-2022, entry version 185.
DE   RecName: Full=Protein OS-9;
DE   AltName: Full=Amplified in osteosarcoma 9;
DE   Flags: Precursor;
GN   Name=OS9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8634085;
RX   DOI=10.1002/(sici)1098-2744(199604)15:4<270::aid-mc4>3.0.co;2-k;
RA   Su Y.A., Hutter C.M., Trent J.M., Meltzer P.S.;
RT   "Complete sequence analysis of a gene (OS-9) ubiquitously expressed in
RT   human tissues and amplified in sarcomas.";
RL   Mol. Carcinog. 15:270-275(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=9498564; DOI=10.1093/oxfordjournals.jbchem.a021880;
RA   Kimura Y., Nakazawa M., Tsuchiya N., Asakawa S., Shimizu N., Yamada M.;
RT   "Genomic organization of the OS-9 gene amplified in human sarcomas.";
RL   J. Biochem. 122:1190-1195(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), CHARACTERIZATION, AND
RP   ALTERNATIVE SPLICING (ISOFORMS 2 AND 3).
RC   TISSUE=Promyelocytic leukemia;
RX   PubMed=9562620; DOI=10.1093/oxfordjournals.jbchem.a022019;
RA   Kimura Y., Nakazawa M., Yamada M.;
RT   "Cloning and characterization of three isoforms of OS-9 cDNA and expression
RT   of the OS-9 gene in various human tumor cell lines.";
RL   J. Biochem. 123:876-882(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 4; 5; 6 AND 8), AND
RP   VARIANT ASN-305.
RC   TISSUE=Brain, Tongue, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 194-667.
RX   PubMed=9192850; DOI=10.1006/geno.1997.4727;
RA   Elkahloun A.G., Krizman D.B., Wang Z., Hofmann T.A., Roe B.A.,
RA   Meltzer P.S.;
RT   "Transcript mapping in a 46-kb sequenced region at the core of 12q13.3
RT   amplification in human cancers.";
RL   Genomics 42:295-301(1997).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=10403379; DOI=10.1016/s0014-5793(99)00700-0;
RA   Nakayama T., Yaoi T., Kuwajima G., Yoshie O., Sakata T.;
RT   "Ca2(+)-dependent interaction of N-copine, a member of the two C2 domain
RT   protein family, with OS-9, the product of a gene frequently amplified in
RT   osteosarcoma.";
RL   FEBS Lett. 453:77-80(1999).
RN   [11]
RP   FUNCTION IN TRPV4 MATURATION.
RX   PubMed=17932042; DOI=10.1074/jbc.m703903200;
RA   Wang Y., Fu X., Gaiser S., Koettgen M., Kramer-Zucker A., Walz G.,
RA   Wegierski T.;
RT   "OS-9 regulates the transit and polyubiquitination of TRPV4 in the
RT   endoplasmic reticulum.";
RL   J. Biol. Chem. 282:36561-36570(2007).
RN   [12]
RP   FUNCTION, ALTERNATIVE SPLICING (ISOFORMS 1 AND 2), SUBCELLULAR LOCATION,
RP   DISULFIDE BONDS, GLYCOSYLATION, INDUCTION, AND MUTAGENESIS OF ARG-188.
RX   PubMed=18417469; DOI=10.1074/jbc.m802272200;
RA   Bernasconi R., Pertel T., Luban J., Molinari M.;
RT   "A dual task for the Xbp1-responsive OS-9 variants in the mammalian
RT   endoplasmic reticulum: inhibiting secretion of misfolded protein conformers
RT   and enhancing their disposal.";
RL   J. Biol. Chem. 283:16446-16454(2008).
RN   [13]
RP   INTERACTION WITH ERLEC1; HSPA5; SEL1L AND SYVN1.
RX   PubMed=18502753; DOI=10.1074/jbc.m709336200;
RA   Hosokawa N., Wada I., Nagasawa K., Moriyama T., Okawa K., Nagata K.;
RT   "Human XTP3-B forms an endoplasmic reticulum quality control scaffold with
RT   the HRD1-SEL1L ubiquitin ligase complex and BiP.";
RL   J. Biol. Chem. 283:20914-20924(2008).
RN   [14]
RP   FUNCTION, INTERACTION WITH HSP90B1; SEL1L AND SYVN1, SUBCELLULAR LOCATION,
RP   GLYCOSYLATION, AND MUTAGENESIS OF ARG-188.
RX   PubMed=18264092; DOI=10.1038/ncb1689;
RA   Christianson J.C., Shaler T.A., Tyler R.E., Kopito R.R.;
RT   "OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L
RT   ubiquitin ligase complex for ERAD.";
RL   Nat. Cell Biol. 10:272-282(2008).
RN   [15]
RP   FUNCTION AS A LECTIN, AND MUTAGENESIS OF ARG-188.
RX   PubMed=19346256; DOI=10.1074/jbc.m809725200;
RA   Hosokawa N., Kamiya Y., Kamiya D., Kato K., Nagata K.;
RT   "Human OS-9, a lectin required for glycoprotein endoplasmic reticulum-
RT   associated degradation, recognizes mannose-trimmed N-glycans.";
RL   J. Biol. Chem. 284:17061-17068(2009).
RN   [16]
RP   FUNCTION IN MISFOLDED GLYCOPROTEIN UBIQUITINATION, SUBCELLULAR LOCATION,
RP   GLYCOSYLATION, INTERACTION WITH DERL2; HRD1 AND SEL1L, AND INDUCTION BY ER
RP   STRESS.
RX   PubMed=19084021; DOI=10.1016/j.jmb.2008.11.045;
RA   Alcock F., Swanton E.;
RT   "Mammalian OS-9 is upregulated in response to endoplasmic reticulum stress
RT   and facilitates ubiquitination of misfolded glycoproteins.";
RL   J. Mol. Biol. 385:1032-1042(2009).
RN   [17]
RP   INTERACTION WITH CREB3.
RX   PubMed=20546900; DOI=10.1016/j.molimm.2010.04.019;
RA   Eleveld-Trancikova D., Sanecka A., van Hout-Kuijer M.A., Looman M.W.,
RA   Hendriks I.A., Jansen B.J., Adema G.J.;
RT   "DC-STAMP interacts with ER-resident transcription factor LUMAN which
RT   becomes activated during DC maturation.";
RL   Mol. Immunol. 47:1963-1973(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   IDENTIFICATION IN THE HRD1 COMPLEX.
RX   PubMed=28827405; DOI=10.1242/jcs.206847;
RA   Schulz J., Avci D., Queisser M.A., Gutschmidt A., Dreher L.S., Fenech E.J.,
RA   Volkmar N., Hayashi Y., Hoppe T., Christianson J.C.;
RT   "Conserved cytoplasmic domains promote Hrd1 ubiquitin ligase complex
RT   formation for ER-associated degradation (ERAD).";
RL   J. Cell Sci. 130:3322-3335(2017).
RN   [21] {ECO:0007744|PDB:3AIH}
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 108-229 IN COMPLEX WITH
RP   MANNOPENTAOSE, FUNCTION, AND DISULFIDE BONDS.
RX   PubMed=21172656; DOI=10.1016/j.molcel.2010.11.017;
RA   Satoh T., Chen Y., Hu D., Hanashima S., Yamamoto K., Yamaguchi Y.;
RT   "Structural basis for oligosaccharide recognition of misfolded
RT   glycoproteins by OS-9 in ER-associated degradation.";
RL   Mol. Cell 40:905-916(2010).
CC   -!- FUNCTION: Lectin which functions in endoplasmic reticulum (ER) quality
CC       control and ER-associated degradation (ERAD). May bind terminally
CC       misfolded non-glycosylated proteins as well as improperly folded
CC       glycoproteins, retain them in the ER, and possibly transfer them to the
CC       ubiquitination machinery and promote their degradation. Possible
CC       targets include TRPV4. {ECO:0000269|PubMed:17932042,
CC       ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:18417469,
CC       ECO:0000269|PubMed:19084021, ECO:0000269|PubMed:19346256,
CC       ECO:0000269|PubMed:21172656}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with CPNE6 (via second C2 domain);
CC       this interaction occurs in a calcium-dependent manner in vitro (By
CC       similarity). Component of the HRD1 complex, which comprises at least
CC       SYNV1/HRD1, DERL1/2, FAM8A1, HERPUD1/HERP, OS9, SEL1L and UBE2J1.
CC       FAM8A1 is stabilized by interaction with SYNV1, which prevents its
CC       proteasomal degradation. OS9 and UBE2J1 recruitment to the complex may
CC       be mediated by SEL1L (PubMed:18502753, PubMed:18264092,
CC       PubMed:19084021, PubMed:28827405). Through this complex, may interact
CC       with ERLEC1 and HSPA5 (PubMed:18502753). Interacts with HSP90B1
CC       (PubMed:18264092). Interacts with CREB3 (PubMed:20546900).
CC       {ECO:0000250|UniProtKB:Q8K2C7, ECO:0000269|PubMed:18264092,
CC       ECO:0000269|PubMed:18502753, ECO:0000269|PubMed:19084021,
CC       ECO:0000269|PubMed:20546900, ECO:0000269|PubMed:28827405}.
CC   -!- INTERACTION:
CC       Q13438; Q9GZT9: EGLN1; NbExp=4; IntAct=EBI-725454, EBI-1174818;
CC       Q13438; Q9H6Z9: EGLN3; NbExp=2; IntAct=EBI-725454, EBI-1175354;
CC       Q13438; O75460-1: ERN1; NbExp=2; IntAct=EBI-725454, EBI-15600828;
CC       Q13438; Q16665: HIF1A; NbExp=9; IntAct=EBI-725454, EBI-447269;
CC       Q13438; Q9UBV2: SEL1L; NbExp=11; IntAct=EBI-725454, EBI-358766;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:18417469,
CC       ECO:0000269|PubMed:19084021}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1; Synonyms=OS-9-1;
CC         IsoId=Q13438-1; Sequence=Displayed;
CC       Name=2; Synonyms=OS-9-2;
CC         IsoId=Q13438-2; Sequence=VSP_004353;
CC       Name=3; Synonyms=OS-9-3;
CC         IsoId=Q13438-3; Sequence=VSP_004352, VSP_004353;
CC       Name=4;
CC         IsoId=Q13438-4; Sequence=VSP_004352;
CC       Name=5;
CC         IsoId=Q13438-5; Sequence=VSP_044701, VSP_044702, VSP_004353;
CC       Name=6;
CC         IsoId=Q13438-6; Sequence=VSP_046001, VSP_004353;
CC       Name=7;
CC         IsoId=Q13438-7; Sequence=VSP_044702, VSP_004353;
CC       Name=8;
CC         IsoId=Q13438-8; Sequence=VSP_046770, VSP_004352, VSP_004353;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Found as well in all tumor
CC       cell lines analyzed, amplified in sarcomas. Highly expressed in
CC       osteosarcoma SJSA-1 and rhabdomyosarcoma Rh30 cell lines. Isoform 2 is
CC       the major isoform detected in all cell types examined.
CC   -!- INDUCTION: Up-regulated in response to endoplasmic reticulum stress (at
CC       protein level). {ECO:0000269|PubMed:18417469,
CC       ECO:0000269|PubMed:19084021}.
CC   -!- PTM: Intramolecular disulfide bonds.
CC   -!- PTM: Isoform 1 and isoform 2 are N-glycosylated.
CC       {ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:18417469,
CC       ECO:0000269|PubMed:19084021}.
CC   -!- MISCELLANEOUS: [Isoform 1]: Major isoform.
CC   -!- MISCELLANEOUS: [Isoform 2]: Major isoform. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the OS-9 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U41635; AAB06495.1; -; mRNA.
DR   EMBL; AB002805; BAA24362.1; -; Genomic_DNA.
DR   EMBL; AB002806; BAA24363.1; -; mRNA.
DR   EMBL; AK291374; BAF84063.1; -; mRNA.
DR   EMBL; AK293435; BAG56939.1; -; mRNA.
DR   EMBL; AK296770; BAG59349.1; -; mRNA.
DR   EMBL; AK298532; BAG60733.1; -; mRNA.
DR   EMBL; AK303858; BAG64798.1; -; mRNA.
DR   EMBL; CR456791; CAG33072.1; -; mRNA.
DR   EMBL; AC025165; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97045.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97046.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW97047.1; -; Genomic_DNA.
DR   EMBL; BC000532; AAH00532.1; -; mRNA.
DR   EMBL; BC007254; AAH07254.1; -; mRNA.
DR   EMBL; BC023513; AAH23513.2; -; mRNA.
DR   EMBL; U81031; AAC39523.2; -; Genomic_DNA.
DR   CCDS; CCDS31843.1; -. [Q13438-1]
DR   CCDS; CCDS31844.1; -. [Q13438-2]
DR   CCDS; CCDS31845.1; -. [Q13438-4]
DR   CCDS; CCDS31846.1; -. [Q13438-3]
DR   CCDS; CCDS58246.1; -. [Q13438-6]
DR   CCDS; CCDS58247.1; -. [Q13438-7]
DR   CCDS; CCDS58248.1; -. [Q13438-5]
DR   CCDS; CCDS58249.1; -. [Q13438-8]
DR   PIR; JC5889; JC5889.
DR   RefSeq; NP_001017956.1; NM_001017956.2. [Q13438-2]
DR   RefSeq; NP_001017957.1; NM_001017957.2. [Q13438-3]
DR   RefSeq; NP_001017958.1; NM_001017958.2. [Q13438-4]
DR   RefSeq; NP_001248349.1; NM_001261420.1. [Q13438-7]
DR   RefSeq; NP_001248350.1; NM_001261421.1. [Q13438-5]
DR   RefSeq; NP_001248351.1; NM_001261422.1. [Q13438-6]
DR   RefSeq; NP_001248352.1; NM_001261423.1. [Q13438-8]
DR   RefSeq; NP_006803.1; NM_006812.3. [Q13438-1]
DR   PDB; 3AIH; X-ray; 2.10 A; A/B=108-229.
DR   PDBsum; 3AIH; -.
DR   AlphaFoldDB; Q13438; -.
DR   SMR; Q13438; -.
DR   BioGRID; 116156; 233.
DR   CORUM; Q13438; -.
DR   DIP; DIP-37493N; -.
DR   IntAct; Q13438; 104.
DR   MINT; Q13438; -.
DR   STRING; 9606.ENSP00000318165; -.
DR   TCDB; 8.A.67.1.1; the os-9 quality control (erad) protein (os-9) family.
DR   UniLectin; Q13438; -.
DR   GlyConnect; 1666; 8 N-Linked glycans (1 site).
DR   GlyGen; Q13438; 2 sites, 10 N-linked glycans (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q13438; -.
DR   PhosphoSitePlus; Q13438; -.
DR   BioMuta; OS9; -.
DR   DMDM; 3024310; -.
DR   EPD; Q13438; -.
DR   jPOST; Q13438; -.
DR   MassIVE; Q13438; -.
DR   MaxQB; Q13438; -.
DR   PaxDb; Q13438; -.
DR   PeptideAtlas; Q13438; -.
DR   PRIDE; Q13438; -.
DR   ProteomicsDB; 17218; -.
DR   ProteomicsDB; 18799; -.
DR   ProteomicsDB; 28738; -.
DR   ProteomicsDB; 33680; -.
DR   ProteomicsDB; 59432; -. [Q13438-1]
DR   ProteomicsDB; 59433; -. [Q13438-2]
DR   ProteomicsDB; 59434; -. [Q13438-3]
DR   ProteomicsDB; 59435; -. [Q13438-4]
DR   Antibodypedia; 2459; 289 antibodies from 29 providers.
DR   DNASU; 10956; -.
DR   Ensembl; ENST00000257966.12; ENSP00000257966.8; ENSG00000135506.16. [Q13438-7]
DR   Ensembl; ENST00000315970.12; ENSP00000318165.7; ENSG00000135506.16. [Q13438-1]
DR   Ensembl; ENST00000389142.9; ENSP00000373794.5; ENSG00000135506.16. [Q13438-3]
DR   Ensembl; ENST00000389146.10; ENSP00000373798.6; ENSG00000135506.16. [Q13438-4]
DR   Ensembl; ENST00000435406.6; ENSP00000389632.2; ENSG00000135506.16. [Q13438-6]
DR   Ensembl; ENST00000439210.6; ENSP00000407360.2; ENSG00000135506.16. [Q13438-8]
DR   Ensembl; ENST00000551035.5; ENSP00000447866.1; ENSG00000135506.16. [Q13438-5]
DR   Ensembl; ENST00000552285.5; ENSP00000450010.1; ENSG00000135506.16. [Q13438-2]
DR   GeneID; 10956; -.
DR   KEGG; hsa:10956; -.
DR   MANE-Select; ENST00000315970.12; ENSP00000318165.7; NM_006812.4; NP_006803.1.
DR   UCSC; uc001spj.4; human. [Q13438-1]
DR   CTD; 10956; -.
DR   DisGeNET; 10956; -.
DR   GeneCards; OS9; -.
DR   HGNC; HGNC:16994; OS9.
DR   HPA; ENSG00000135506; Low tissue specificity.
DR   MIM; 609677; gene.
DR   neXtProt; NX_Q13438; -.
DR   OpenTargets; ENSG00000135506; -.
DR   PharmGKB; PA164724245; -.
DR   VEuPathDB; HostDB:ENSG00000135506; -.
DR   eggNOG; KOG3394; Eukaryota.
DR   GeneTree; ENSGT00530000063603; -.
DR   HOGENOM; CLU_026715_0_0_1; -.
DR   InParanoid; Q13438; -.
DR   OMA; WLKRLYV; -.
DR   OrthoDB; 1475416at2759; -.
DR   PhylomeDB; Q13438; -.
DR   TreeFam; TF314309; -.
DR   PathwayCommons; Q13438; -.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants are degraded by ERAD.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   SignaLink; Q13438; -.
DR   SIGNOR; Q13438; -.
DR   BioGRID-ORCS; 10956; 29 hits in 1088 CRISPR screens.
DR   ChiTaRS; OS9; human.
DR   EvolutionaryTrace; Q13438; -.
DR   GeneWiki; OS9_(gene); -.
DR   GenomeRNAi; 10956; -.
DR   Pharos; Q13438; Tbio.
DR   PRO; PR:Q13438; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q13438; protein.
DR   Bgee; ENSG00000135506; Expressed in calcaneal tendon and 211 other tissues.
DR   ExpressionAtlas; Q13438; baseline and differential.
DR   Genevisible; Q13438; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0000836; C:Hrd1p ubiquitin ligase complex; NAS:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0002020; F:protease binding; IEA:Ensembl.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:InterPro.
DR   GO; GO:1904153; P:negative regulation of retrograde protein transport, ER to cytosol; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006621; P:protein retention in ER lumen; IDA:UniProtKB.
DR   GO; GO:0006605; P:protein targeting; IEA:Ensembl.
DR   GO; GO:0016567; P:protein ubiquitination; IMP:UniProtKB.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB.
DR   GO; GO:0030970; P:retrograde protein transport, ER to cytosol; IBA:GO_Central.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   Gene3D; 2.70.130.10; -; 1.
DR   InterPro; IPR009011; Man6P_isomerase_rcpt-bd_dom_sf.
DR   InterPro; IPR044865; MRH_dom.
DR   InterPro; IPR045149; OS-9-like.
DR   InterPro; IPR012913; OS9-like_dom.
DR   PANTHER; PTHR15414; PTHR15414; 1.
DR   Pfam; PF07915; PRKCSH; 1.
DR   SUPFAM; SSF50911; SSF50911; 1.
DR   PROSITE; PS51914; MRH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Lectin; Reference proteome; Signal.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..667
FT                   /note="Protein OS-9"
FT                   /id="PRO_0000021951"
FT   DOMAIN          108..230
FT                   /note="MRH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01262"
FT   REGION          284..355
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          372..452
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          464..483
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          504..540
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          633..667
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        301..315
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        392..411
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        412..432
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        433..452
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         117
FT                   /ligand="a mannooligosaccharide derivative"
FT                   /ligand_id="ChEBI:CHEBI:71274"
FT                   /evidence="ECO:0000269|PubMed:21172656,
FT                   ECO:0007744|PDB:3AIH"
FT   BINDING         118
FT                   /ligand="a mannooligosaccharide derivative"
FT                   /ligand_id="ChEBI:CHEBI:71274"
FT                   /evidence="ECO:0000269|PubMed:21172656,
FT                   ECO:0007744|PDB:3AIH"
FT   BINDING         130
FT                   /ligand="a mannooligosaccharide derivative"
FT                   /ligand_id="ChEBI:CHEBI:71274"
FT                   /evidence="ECO:0000269|PubMed:21172656,
FT                   ECO:0007744|PDB:3AIH"
FT   BINDING         182
FT                   /ligand="a mannooligosaccharide derivative"
FT                   /ligand_id="ChEBI:CHEBI:71274"
FT                   /evidence="ECO:0000269|PubMed:21172656,
FT                   ECO:0007744|PDB:3AIH"
FT   BINDING         188
FT                   /ligand="a mannooligosaccharide derivative"
FT                   /ligand_id="ChEBI:CHEBI:71274"
FT                   /evidence="ECO:0000269|PubMed:21172656,
FT                   ECO:0007744|PDB:3AIH"
FT   BINDING         212
FT                   /ligand="a mannooligosaccharide derivative"
FT                   /ligand_id="ChEBI:CHEBI:71274"
FT                   /evidence="ECO:0000269|PubMed:21172656,
FT                   ECO:0007744|PDB:3AIH"
FT   BINDING         218
FT                   /ligand="a mannooligosaccharide derivative"
FT                   /ligand_id="ChEBI:CHEBI:71274"
FT                   /evidence="ECO:0000269|PubMed:21172656,
FT                   ECO:0007744|PDB:3AIH"
FT   CARBOHYD        177
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        110..123
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01262"
FT   DISULFID        181..216
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01262"
FT   DISULFID        196..228
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01262"
FT   VAR_SEQ         55..113
FT                   /note="Missing (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046770"
FT   VAR_SEQ         142..193
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046001"
FT   VAR_SEQ         161..193
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044701"
FT   VAR_SEQ         263
FT                   /note="A -> AV (in isoform 5 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044702"
FT   VAR_SEQ         456..470
FT                   /note="Missing (in isoform 3, isoform 4 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_004352"
FT   VAR_SEQ         534..588
FT                   /note="Missing (in isoform 2, isoform 3, isoform 5, isoform
FT                   6, isoform 7 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.5"
FT                   /id="VSP_004353"
FT   VARIANT         305
FT                   /note="D -> N (in dbSNP:rs141986192)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_069062"
FT   VARIANT         398
FT                   /note="R -> W (in dbSNP:rs1804598)"
FT                   /id="VAR_011897"
FT   VARIANT         454
FT                   /note="S -> L (in dbSNP:rs34764811)"
FT                   /id="VAR_034364"
FT   MUTAGEN         188
FT                   /note="R->A: Loss of glycan-binding activity and partial
FT                   inhibition of ERAD of the misfolded glycoprotein NHK
FT                   (PubMed:19346256). Reduced interaction with SEL1L
FT                   (PubMed:18264092) not confirmed in (PubMed:19346256)."
FT                   /evidence="ECO:0000269|PubMed:18264092,
FT                   ECO:0000269|PubMed:18417469, ECO:0000269|PubMed:19346256"
FT   CONFLICT        7
FT                   /note="L -> V (in Ref. 5; CAG33072)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        194
FT                   /note="F -> V (in Ref. 4; BAG64798)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        371
FT                   /note="E -> G (in Ref. 4; BAG56939)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        497
FT                   /note="L -> F (in Ref. 4; BAG64798)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        522
FT                   /note="V -> I (in Ref. 4; BAG60733)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        653
FT                   /note="S -> P (in Ref. 4; BAG56939)"
FT                   /evidence="ECO:0000305"
FT   STRAND          111..115
FT                   /evidence="ECO:0007829|PDB:3AIH"
FT   STRAND          118..123
FT                   /evidence="ECO:0007829|PDB:3AIH"
FT   TURN            124..126
FT                   /evidence="ECO:0007829|PDB:3AIH"
FT   STRAND          127..131
FT                   /evidence="ECO:0007829|PDB:3AIH"
FT   STRAND          143..155
FT                   /evidence="ECO:0007829|PDB:3AIH"
FT   STRAND          169..176
FT                   /evidence="ECO:0007829|PDB:3AIH"
FT   TURN            182..184
FT                   /evidence="ECO:0007829|PDB:3AIH"
FT   STRAND          189..196
FT                   /evidence="ECO:0007829|PDB:3AIH"
FT   STRAND          206..214
FT                   /evidence="ECO:0007829|PDB:3AIH"
FT   STRAND          217..224
FT                   /evidence="ECO:0007829|PDB:3AIH"
FT   HELIX           225..227
FT                   /evidence="ECO:0007829|PDB:3AIH"
SQ   SEQUENCE   667 AA;  75562 MW;  65BA3F66CEC58756 CRC64;
     MAAETLLSSL LGLLLLGLLL PASLTGGVGS LNLEELSEMR YGIEILPLPV MGGQSQSSDV
     VIVSSKYKQR YECRLPAGAI HFQREREEET PAYQGPGIPE LLSPMRDAPC LLKTKDWWTY
     EFCYGRHIQQ YHMEDSEIKG EVLYLGYYQS AFDWDDETAK ASKQHRLKRY HSQTYGNGSK
     CDLNGRPREA EVRFLCDEGA GISGDYIDRV DEPLSCSYVL TIRTPRLCPH PLLRPPPSAA
     PQAILCHPSL QPEEYMAYVQ RQADSKQYGD KIIEELQDLG PQVWSETKSG VAPQKMAGAS
     PTKDDSKDSD FWKMLNEPED QAPGGEEVPA EEQDPSPEAA DSASGAPNDF QNNVQVKVIR
     SPADLIRFIE ELKGGTKKGK PNIGQEQPVD DAAEVPQREP EKERGDPERQ REMEEEEDED
     EDEDEDEDER QLLGEFEKEL EGILLPSDRD RLRSEVKAGM ERELENIIQE TEKELDPDGL
     KKESERDRAM LALTSTLNKL IKRLEEKQSP ELVKKHKKKR VVPKKPPPSP QPTEEDPEHR
     VRVRVTKLRL GGPNQDLTVL EMKRENPQLK QIEGLVKELL EREGLTAAGK IEIKIVRPWA
     EGTEEGARWL TDEDTRNLKE IFFNILVPGA EEAQKERQRQ KELESNYRRV WGSPGGEGTG
     DLDEFDF
//
